Latest Protein-bound paclitaxel Stories

2014-01-17 20:21:56

MELBOURNE, Australia, Jan. 17, 2014 /PRNewswire/ -- -- Study shows ABRAXANE plus gemcitabine combination therapy further extends overall survival benefit -- First Phase III trial in metastatic pancreatic cancer to report three year survival rates[1] -- New standard of care for patients with metastatic pancreatic cancer A leading breast cancer drug, ABRAXANE(®)( )(nanoparticle albumin-bound paclitaxel), has been shown to extend overall survival (OS) for...

2013-10-17 16:30:52

NEJM today publishes findings of international trial resulting in recent FDA approval of Abraxane (nab-paclitaxel) for patients with advanced pancreatic cancer By all measures, the addition of nab-paclitaxel for the treatment of patients with advanced pancreatic cancer was superior to the survival for patients who received only gemcitabine, according to the results of a study led by the Translational Genomics Research Institute (TGen) and Scottsdale Healthcare, published today by The New...

2013-10-03 23:22:52

Reportbuyer.com just published a new market research report: PharmaPoint: Non-Small Cell Lung Cancer - US Drug Forecast and Market Analysis to 2022. London (PRWEB) October 03, 2013 PharmaPoint: Non-Small Cell Lung Cancer - US Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of...

Word of the Day
  • Remarkable; prodigious.
  • Audacious; gutsy.
  • Completely; extremely.
  • Audaciously; boldly.
  • Impressively great in size; enormous; extraordinary.
This word is probably from the dialectal 'boldacious,' a blend of 'bold' and 'audacious.'